The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
International Trends in the Incidence of Testicular Cancer, 1973-2002
Open accessAbstract
Background: Whereas testicular cancer incidence rates have been widely reported in populations of Northern European ancestry, rates in other populations have been less frequently examined. In a prior report, global testicular cancer incidence rates and trends for the years 1973 to 1997 were summarized. The current report extends these analyses with an additional 5 years of data from Cancer Incidence in Five Continents. Methods: Age-standardized incidence rates over successive 5-year time periods were obtained for populations in the Americas, Asia, Europe, and Oceania. Results: In general, testicular cancer incidence remained highest in Northern European populations (8.0-9.0 per 100,000) and lowest in Asian and African populations (<1 per 100,000). One notable exception to this pattern, however, was the very high rate reported by the Valdivia, Chile registry (8.8 per 100,000). In many populations, rates rose between 1973 and 2002, although the increases were strongest and most consistent among populations of European ancestry. In certain European populations, such as those of Denmark and of Geneva, Switzerland, some recent plateauing of rates was evident. There was little evidence of increase and possible evidence of a modest decline in rates among east Asian populations. Trends by histology (seminoma and nonseminoma) were generally similar to one another. Conclusions: Risk of testicular cancer remains relatively high in Northern European populations and low in Asian and African populations. Similar trends by histology suggest common risk factors. Effect: Reasons for increasing rates among Northern Europeans and stable or declining rates among East Asians are unexplained, supporting the need for future etiologic studies. Cancer Epidemiol Biomarkers Prev; 19(5); 1151–9. ©2010 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract?
Sharpe, R. M., & Skakkebaek, N. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)90953-e · Cited by 1,849
Testicular germ-cell tumours in a broader perspective
Oosterhuis, J. W., & Looijenga, L. H. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1568 · Cited by 916
Increasing Incidence of Testicular Cancer Worldwide: A Review
HUYGHE, E., MATSUDA, T., & THONNEAU, P. (2003) · Journal of Urology · doi:10.1097/01.ju.0000053866.68623.da · Cited by 605
Increase in Testicular Cancer Incidence in Six European Countries: a Birth Cohort Phenomenon
Bergström, R., Adami, H.-O., Möhner, M., Zatonski, W., Storm, H., Ekbom, A., Tretli, S., Teppo, L., Akre, O., & Hakulinen, T. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.11.727 · Cited by 439
Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches
Møller, B., Fekjær, H., Hakulinen, T., Sigvaldason, H., Storm, H. H., Talbäck, M., & Haldorsen, T. (2003) · Statistics in Medicine · doi:10.1002/sim.1481 · Cited by 338
Trends in the incidence of testicular germ cell tumors in the United States
McGlynn, K. A., Devesa, S. S., Sigurdson, A. J., Brown, L. M., Tsao, L., & Tarone, R. E. (2003) · Cancer · doi:10.1002/cncr.11054 · Cited by 338
Self-citationForman, D., Pike, M. C., Davey, G., Dawson, S., Baker, K., Chilvers, C. E. D., Oliver, R. T. D., & Coupland, C. A. C. (1994) · BMJ · doi:10.1136/bmj.308.6941.1393 · Cited by 329
Testicular Cancer Incidence in Eight Northern European Countries: Secular and Recent Trends
Richiardi, L., Bellocco, R., Adami, H.-O., Torrång, A., Barlow, L., Hakulinen, T., Rahu, M., Stengrevics, A., Storm, H., Tretli, S., et al. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.2157.13.12 · Cited by 254
International patterns and trends in testis cancer incidence
Purdue, M. P., Devesa, S. S., Sigurdson, A. J., & McGlynn, K. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.20931 · Cited by 231
Self-citation
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
State-of-the-science of endocrine disrupting chemicals, 2012
Bergman, Å., Heindel, J., Jobling, S., Kidd, K., & Zoeller, R. T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.020 · Cited by 1,388
Global cancer patterns: causes and prevention
Vineis, P., & Wild, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62224-2 · Cited by 709
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Gilligan, T., Lin, D. W., Aggarwal, R., Chism, D., Cost, N., Derweesh, I. H., Emamekhoo, H., Feldman, D. R., Geynisman, D. M., Hancock, S. L., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0058 · Cited by 450
Sifakis, S., Androutsopoulos, V. P., Tsatsakis, A. M., & Spandidos, D. A. (2017) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2017.02.024 · Cited by 427
Metadata
- Authors
- Chia, V. M., Quraishi, S. M., Devesa, S. S., Purdue, M. P., Cook, M. B., & McGlynn, K. A.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2010-05-01
- Volume
- 19
- Issue
- 5
- Pages
- 1151-1159
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2140211014
- Cited by
- 303
- References
- 46
- FWCI
- 26.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: International Trends in the Incidence of Testicular Cancer, 1973-2002. https://app.cochat.ai/papers/10.1158/1055-9965.epi-10-0031
- The paper
- Chia, V. M., Quraishi, S. M., Devesa, S. S., Purdue, M. P., Cook, M. B., & McGlynn, K. A. (2010). International Trends in the Incidence of Testicular Cancer, 1973-2002. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-10-0031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.